Resibufogenin is one of the major active components of the Chinese medicine ChanSu. In this paper, microbial transformation of resibufogenin by Absidia coerules AS 3.3382 was investigated and five metabolites were isolated and identified as 5β-hydroxy-resibufogenin (2), 3-epi-resibufogenin (3), 3α-hydroxy-15-oxo-14αH-bufa-20, 22-dienolide (4), 3α,14α,15β-trihydroxy-bufa-20, 22-dienolide (5) and 3-epi-15β-hydroxy-bufalin (6). Among them, 4-6 are novel compounds, and compound 3 is a major transformed product. The cytotoxicities of the compounds against Bel-7402 and Hela cells were investigated, and our result suggested that 14,15-OH configuration was directly related to the cytotoxicities of bufadienolides.
Chansu, a traditional Chinese medicine, is made of the skin secretions of giant toads including Bufo bufo gararizans Cantor and Bufo bufo melanostictus Schneider [1, 2] . Its major active components are bufadienolides, such as resibufogenin, cinobufagin and bufalin, with strong cardiac, blood pressure-stimulating, and antiviral activities. In recent years, bufadienolides have been regarded as one of the strongest anticancer agents [3, 4] . Meanwhile, resibufogenin is one of main bioactive bufadienolides with a content as high as 3% in the crude drug. The compound has steroidal A/B cis and C/D cis ring junctions with a characteristic α-pyrone ring at C-17, and a 14β,15βepoxide [5a] . Resibufogenin has been reported to exhibit significant inhibitory activities against human leukemia (HL60), human cervical carcinoma (Hela) and human hepatoma cells (Bel7402), with IC 50 values of 1-10 nM [5b]. However, poor water-solubility and side effects limited its clinical usage as an antitumor drug.
Biotransformation is a useful technique in the structural modification of natural compounds due to its stereoselectivity. A large number of bufadienolide derivatives with novel chemical structures have been obtained by biotransformation technology [6, 7] . Another important application of biotransformation is its use as an in vitro model to simulate drug metabolism in mammals, due to the similar metabolic enzymes of the microorganisms and The UV absorption maxima of these new peaks were at 294-298 nm, which is characteristic for an α-pyrone ring of bufadienolides, suggesting that they were the transformed products of 1. Therefore, this was selected for preparative biotransformation. Five compounds were obtained and their chemical structures ( Figure 1 ) were identified by extensive spectral techniques.
Identification of biotransformed products: Compounds 2 and 3 were identified as 5β-hydroxy-resibufogenin and 3-epi-resibufogenin, respectively, on the basis of their 1 H and 13 C NMR spectroscopic data [8, 9] . ) and C-18 (δ 13.6), respectively. In the 1 H-1 H COSY spectrum, correlation between H-8 and H-14 was observed. This evidence suggested that the carbonyl group should be at C-15. In the NOESY spectrum, the NOE enhancement between H-14 and H-17 suggested that H-14 should be in an α-configuration. On the basis of the above analysis, 4 was identified as 3α-hydroxy-15-oxo-14αH-bufa-20,22dienolide. All 1 H and 13 C NMR spectral data were unambiguously assigned from 2D-NMR spectra (Tables 1  and 2 ). Although a number of transformed products have been reported before, this is the first report of the 15-oxobufadienolide derivative.
Compound 5 was obtained as a white powder. Its HR-MS showed an [M+H] + ion peak at m/z 403.2321, indicating the molecular formula of C 24 H 34 O 5 . Compared with 1, the oxygen-bearing carbon signals at C-14 (δ 74.0) and C-15 (δ 59.3) of 1 disappeared, and two additional carbon signals at δ 83.7 and δ7 4.6 were observed in the 13 C NMR spectrum of 5, which indicating that the 14β,15β-epoxy ring was also opened and two hydroxyl groups were located at C-14 and C-15, respectively. In the HMBC spectrum, C-14 (δ 83.7) had long-range correlations with H-15 (δ 3.84), H-16 (δ 2.27) and Me-18 (δ 0.71), respectively. In the 1 H-1 H COSY spectrum, correlation C-NMR spectral data were unambiguously assigned from 2D-NMR spectra ( Tables 1 and 2) . Compound 6 was obtained as a white powder from methanol. Its HR-MS showed an [M+H] + ion peak at m/z 403.2391, indicating the molecular formula of C 24 H 34 O 5 . The carbon signals of 6 were almost the same as those of 15β-hydroxyl-bufalin [6b], and only the carbon signal of C-3 had shifted down to δ 70.1 (+Δδ 5.5). In the NOESY spectrum, H-15 (δ 4.44) had NOE enhancements with H a -16 (δ 2.46) and H-17 (δ 2.29), suggesting that the 15-OH should be in a β-configuration. Therefore, compound 6 was identified as 3-epi-15β-hydroxy-bufalin. All 1 H and 13 C NMR spectral data were unambiguously assigned from 2D-NMR spectra ( Tables 1 and 2 ).
Our results demonstrated that most of the products transformed by A. coerules AS 3.3382 were isomerized derivatives at C-3. Among them, 3-epi-resibufogenin is a major in vivo metabolite of 1 in rat [12a] . 14, 15-Epoxy ring cleavage and peroxidation were observed to yield the novel compounds 4-6. Product 4 was the dehydrogenated derivative of 1 at C-15, which is a rare transformed reaction. Interestingly, compounds 5 and 6 were the isomerized derivatives at C-14, after the 14, 15-epoxy ring had been hydrolyzed. It is well known that the presence of either 14β hydroxyl or 14β, 15β-epoxy groups is assumed to be an integral part of natural bufadienolides. During the past years, many investigations of biotransformation of bufadienolides have been reported, and the transformed products were mostly hydroxylated products [6-9]. However, epoxy ring cleavage was rarely observed, which indicates that the catalytic capability of A. coerules AS 3.3382 to 1 is special. Moreover, epoxy ring cleavage of C-14, 15 would enhance the water-solubility of bufadienolides, and provide new hydroxyl groups for semi-synthesis of novel bufadienolide analogues.
Cytotoxic activity:
The cytotoxicities of the metabolites against Hela and Bel-7402 cells were determined by the MTT bioassay (Table 3 ). Our results indicate that the 3αhydroxyl group decreases the cytotoxic activities, but these activities of 6, with the 14β, 15β-OH configuration, were stronger than those of 5 with the 14α, 15β-OH configuration, which indicates that the 14, 15-OH configuration is related to the cytotoxicities of bufadienolides. Culture medium: Fermentations of fungi were carried out in potato medium made using the following procedures: 200 g of husked potato was boiled in water for 30 min, filtered and the filtrate diluted with water to 1L after the addition of 20 g glucose [11] .
Culture and biotransformation procedures:
Screening scale biotransformations of 1 by microorganisms were carried out in 250 mL Erlenmeyer flasks containing 100 mL of liquid potato medium. Mycelia were transferred into the flasks from the slants. The flasks were placed on rotary shakers operating (180 rpm) at 30 o C. The substrates were dissolved in ethanol to a concentration of 10 mg/mL, and 0.2 mL of this solution was added to each fermentation flask after 24 h. The incubation was allowed to continue for an additional 4 days under the fermentation conditions mentioned above. Culture controls consisted of fermentation blanks in which microorganisms were grown only in the same amount of ethanol. Substrate controls consisted of liquid potato medium containing the same amount of substrate and incubated under the same fermentation conditions.
Preparative scale biotransformation of 1 by A. coerules AS 3.3382 was carried out in 1000 mL Erlenmeyer flasks containing 400 mL of liquid potato medium. Mycelia were transferred into 50 flasks, and the fungus was incubated at 30°C on a rotary shaker (180 rpm) for 36 h. Then, 0.5 mL of the solution containing 20 mg of 1 was added to each fermentation flask. A total amount of 1000 mg of 1 was used for preparative biotransformation. All incubation was continued for an additional 4 days under the fermentation conditions mentioned above.
Extraction, purification and identification of biotransformed products: The culture was filtered in vacuo. The filtrate was extracted 3 times with the same volume of EtOAc to obtain 6 g extract, which was applied 1584 Natural Product Communications Vol. 6 (11) 2011
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to a silica gel column and eluted with light petroleumacetone (from 10:1 to 1:1, v/v) to afford 6 fractions (I-VI). Fraction III was crystallized in acetone to give 3 (605.5 mg). Fraction IV was separated by preparative HPLC and eluted with MeOH-H 2 O (80:20, v/v) to give 2 (16.8 mg) and 4 (6.1 mg). Fraction V was subjected to preparative HPLC and eluted with MeOH-H 2 O (45:55, v/v) to yield 5 (19.6 mg) and 6 (21.4 mg). Purities of all the transformed products were above 96% by Rp-HPLC analysis. Bioassay: Human cervical carcinoma cells (Hela) and human hepatoma (Bel-7402) were maintained in RPMI1640 medium (GIBCO/BRL, Maryland, USA) supplemented with 10% (v/v) fetal bovine serum and cultured in 96 well microtiter plates for the assay. Appropriate dilutions of the test compounds were added to the cultures, and the cells were then cultured at 37 o C, in 5% CO 2 for 72 h. The survival rates of the cancer cells were evaluated by the MTT method [12b]. The activity was shown as the IC 50 value, which is the concentration of test compound to give 50% inhibition of cell growth. Results were expressed as the mean value of triplicate determinations.
